A Safety and Efficacy Study of XH001 Combined With Sintilimab Injection in Advanced Solid Tumors
Clinical trial NCT05940181 · UNKNOWN
Trial details
- NCT number
- NCT05940181
- Sponsor
- jianming xu
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2025-05-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.